Estructura del grupo
27 empresas en 13 países
27 empresas en 13 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 352
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| Allerfre, tabletten 10 mgTablet | Loratadine | Países Bajos | Autorizado | 2002 |
| BENAGOL TOSSE SECCASciroppo | Plantago lanceolata foglie, estratto secco | Italia | Autorizado | |
| BONJELA GEL0.01% w/w + 8.714% W/W · GEL | Cetalkonium, Choline salicylate | Singapur | Autorizado | 1990 |
| CARDIPRIN 100 TABLET 100 mg100 mg · Tablet | Acetylsalicylic acid | Singapur | Autorizado | 1991 |
| CEPACOL CHILDREN'S FRUITY STRAWBERRY0.6 mg + 1.2 mg · Lozenge | Amylmetacresol, Dichlorobenzyl alcohol | Canadá | Comercializado | 2013 |
| CEPACOL INSTASOOTHE SORE THROAT + PAIN RELIEF2 mg · Lozenge | Hexylresorcinol | Canadá | Autorizado | |
| CEPACOL INSTASOOTHE SORE THROAT RELIEF + SOOTHING COMFORT2.4 mg · Lozenge | Hexylresorcinol | Canadá | Comercializado | |
| CEPACOL SENSATIONS0.6 mg + 1.2 mg · Lozenge | Amylmetacresol, Dichlorobenzyl alcohol | Canadá | Comercializado | 2012 |
| CEPACOL SENSATIONS COOL MINT0.6 mg + 1.2 mg + 8 mg · Lozenge | Amylmetacresol, Dichlorobenzyl alcohol, Menthol | Canadá | Autorizado | |
| CEPACOL SENSATIONS SORE THROAT & BLOCKED NOSE0.6 mg + 1.2 mg + 8 mg · Lozenge | Amylmetacresol, Dichlorobenzyl alcohol, Levomenthol | Canadá | Comercializado | 2012 |
| CEPACOL SENSATIONS SORE THROAT & COUGH0.6 mg + 1.2 mg + 8 mg · Lozenge | Amylmetacresol, Dichlorobenzyl alcohol, Menthol | Canadá | Comercializado | 2012 |
| Citrosan, poeder in sachetPoeder voor oraal gebruik | Ascorbic acid, Paracetamol | Países Bajos | Autorizado | 1971 |
| DETTOL4.8 % / w/w · Solution | Chloroxylenol | Canadá | Comercializado | 1938 |
| Dettol Med Benzalkoniumchloride 2 mg/g huidspray, oplossing voor cutaan gebruikHuidspray, oplossing | Benzalkonium | Países Bajos | Autorizado | 2010 |
| Dettol Med Chloorxylenol 48 mg/g, concentraat voor oplossing voor cutaan gebruikConcentraat voor oplossing voor cutaan gebruik | Chloroxylenol | Países Bajos | Autorizado | 2009 |
| Gaviscon 250 mg aardbei, kauwtablettenKauwtablet | Carbonate, Natriumalginaat, Cloreto | Países Bajos | Autorizado | 2005 |
| GAVISCON ADVANCE-PEPPERMINT FLAVOUR SUSPENSION200 mg/10 ml + 1000 mg/10 ml · Suspension | Bicarbonate, Alginate | Singapur | Autorizado | 2004 |
| Gaviscon anijs, suspensieSuspensie voor oraal gebruik | Natriumalginaat, Cloreto | Países Bajos | Autorizado | 1981 |
| GAVISCON COMPRIMIDOS MASTICABLES SABOR FRESA250,000 mg + 133,50 mg + 80,000 mg · Comprimido masticable | Alginate, Bicarbonate, Carbonate | España | Comercializado | 2015 |
| GAVISCON COMPRIMIDOS MASTICABLES SABOR FRESA250 mg + 133,5 mg + 80 mg · Comprimido masticable | Alginate, Bicarbonate, Carbonate | España | Comercializado | 2025 |
| GAVISCON COMPRIMIDOS MASTICABLES SABOR MENTA250,00 mg + 80,00 mg + 133,50 mg · Comprimido masticable | Alginate, Carbonate, Bicarbonate | España | Comercializado | 2011 |
| GAVISCON DOUBLE ACTION LIQUID, SUSPENSION325mg/10ml + 500mg/10ml + 213mg/10ml · Suspension | Carbonate, Alginate, Bicarbonate | Singapur | Autorizado | 2011 |
| GAVISCON DOUBLE ACTION TABLETS187.5mg + 250mg + 106.5mg · Tablet, chewable | Carbonate, Alginate, Bicarbonate | Singapur | Autorizado | 2012 |
| Gaviscon Duo Bosvruchten, kauwtablettenKauwtablet | Carbonate, Natriumalginaat, Cloreto | Países Bajos | Autorizado | 2023 |
| Gaviscon Duo Bosvruchtensmaak 250 mg/106,5 mg /187,5 mg, kauwtablettenKauwtablet | Carbonate, Natriumalginaat, Cloreto | Países Bajos | Autorizado | 2024 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Canadá | 138 | 78 | 60 | EmpresasTodos los medicamentos |
| Países Bajos | 53 | 53 | 0 | EmpresasTodos los medicamentos |
| España | 49 | 39 | 10 | EmpresasTodos los medicamentos |
| Brasil | 33 | 11 | 22 | EmpresasTodos los medicamentos |
| Croacia | 29 | 29 | 0 | EmpresasTodos los medicamentos |
| Singapur | 27 | 27 | 0 | EmpresasTodos los medicamentos |
| Arabia Saudí | 22 | 22 | 0 | EmpresasTodos los medicamentos |
| Italia | 1 | 1 | 0 | EmpresasTodos los medicamentos |
También en los registros de Alemania, Colombia, Francia, Malasia, Reino Unido, Serbia, Suecia
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Fuente de la información: AEMPS (CIMA).
Licencia: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licencia: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licencia: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licencia: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licencia: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licencia: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Reckitt en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaLicencia: CC BY-SA 4.0
Bundesinstitut für Arzneimittel und Medizinprodukte, pediatric list, acquired 2026-10-29T14:36:58.614273+00:00
Licencia: commercial redistribution permission not established
Bundesinstitut für Arzneimittel und Medizinprodukte, urgent list, acquired 2026-10-29T14:36:58.856157+00:00
Licencia: commercial redistribution permission not established
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
GLEIF; exact source URL and retrieval date; no endorsement.
Licencia: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licencia: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
AIFA, https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv, HTTP Last-Modified Mon, 26 Oct 2026 00:02:13 GMT, acquired 2026-10-26T09:43:33.749886+00:00; factual native values retained; exact row correspondence and projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licencia: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licencia: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licencia: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licencia: Singapore Open Data Licence
Grupos farmacéuticos conocidos, cada uno con todas sus empresas.